ArticleAnnals of surgical oncology2025
Defining Low Muscle Mass in Cancer Patients: Sex-Specific Computed Tomography-Derived Cutoff Values and Survival Impact-A Multicenter Cohort Study.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Impact of oral nutritional supplements on chemotherapy tolerance and overall survival in postoperative colorectal cancer patients undergoing chemotherapy.Asia Pacific journal of clinical nutrition · 2026Trial
- Identification of patients at risk for poor survival among those with normal skeletal muscle mass: a multicenter retrospective validation study in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026Article
- Nutritional prehabilitation strategies in abdominal surgery.Current opinion in clinical nutrition and metabolic care · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundLow skeletal muscle mass is associated with adverse cancer outcomes and is a key diagnostic criterion for malnutrition in the Global Leadership Initiative on Malnutrition, emphasizing the importance of muscle mass assessment. This study aimed to establish sex-specific cutoff values for skeletal/psoas muscle mass index (SMI/PMI), calculated from computed tomography, in cancer patients for predicting prognosis.
methodsIn this multicenter cohort study, preoperative SMI and PMI were analyzed in patients with gastric cancer who underwent gastrectomy without preoperative therapy between 2011 and 2016. Using 80% of the cases as a training set, sex-specific cutoffs for overall survival (OS) were determined via the optimal stratification method, adjusted for age and stage. The remaining 20% were used to validate OS differences between high and low muscle-mass groups.
resultsOf 3841 registered patients from 17 hospitals, 3797 were analyzed. Spline plots showed a strong association between lower muscle mass and worse OS in males, but a weaker association in females. The SMI cutoffs were 40 cm
conclusionsThe proposed cutoffs may facilitate the early identification of muscle loss or malnutrition, supporting timely intervention. The observed sex differences highlight the necessity to develop sex-specific strategies for nutritional and muscle mass management during cancer treatment.
Identifiers
40971041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.